CathVision receives competitive EU Grant
CathVision is developing and selling medical devices to treat cardiac arrhythmias
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Nov 19
CathVision is developing and selling medical devices to treat cardiac arrhythmias
01 Nov 19
The Impella 5.5 with SmartAssist has received the U.S. Food and Drug Administration’s (FDA) highest level of approval…
01 Nov 19
The regulatory clearances provide a foundation for bandage and gel-based products that can be used to manage acute…
31 Oct 19
Acquisition of Medidata is expected to help Dassault Systèmes in strengthening its footprint in the digital transformation of…
31 Oct 19
CCM is an advanced electrical therapy that works by modulating the strength of the heart muscle contraction rather…
30 Oct 19
The HeartLight System is a revolutionary catheter ablation technology for controlled and consistent pulmonary vein isolation (PVI), a…
29 Oct 19
The Impella 5.5 has been designed to be inserted into the left ventricle of the heart through either…
25 Oct 19
SupeR BEAT can reproduce the beating of the heart during surgeries using e-Rubber
The nine-year lifespan of Admedus' ADAPT tissue technology could make it the go-to in aortic valve replacement for…
17 Oct 19
The company will hold demos of its innovative FoleySafe, the world's first catheter securement device preventing possible injuries…